Trump Administration revives rebate safe harbor rule in late effort to reform drug pricing
By EsqSocial Corporation 25/11/20
On November 20, 2020, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) finalized its previously abandoned 2019 proposal to exclude certain rebates paid by drug manufacturers from the discount safe harbor to the federal anti-kickback statute (AKS)....
By: Hogan Lovells